Industry Research Reports
Home > Reports > Service & Software > Global Neurology CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Neurology CRO Services Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-11
Pages: 157 Pages
Report ld: 6175253
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Neurology CRO Services Market Size(US$)
CAGR 2026-2032
5.3%
Market Size,2032
USD 1,090
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 799 million
Market Forecast in 2032(Value)
US$ 1,090 million
CAGR
5.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1090 million by 2032, at a CAGR of 5.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Neurology Contract Research Organization (CRO) services are specialized offerings provided by external entities to pharmaceutical companies, biotech firms, academic institutions, and other stakeholders engaged in neurological research and drug development. These CROs possess in-depth expertise in the complex field of neurology, encompassing a wide range of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke. Their services span various stages of the research and development process. They are involved in the design and planning of clinical trials, carefully formulating study protocols, defining appropriate endpoints, and identifying suitable patient populations based on the specific neurological condition under investigation. Neurology CROs handle patient recruitment and enrollment, leveraging their networks with specialized neurology clinics, hospitals, and patient advocacy groups to ensure a diverse and representative sample of participants. They also manage data collection, analysis, and interpretation, dealing with the intricate data related to neurological symptoms, cognitive function, and biomarker measurements. Additionally, they offer regulatory support, helping clients navigate the complex and evolving regulatory landscape for neurological therapies, ensuring compliance with relevant guidelines. These services are essential for accelerating the development of effective treatments for neurological disorders, as they allow organizations to access the specialized skills, resources, and experience of the CROs, ultimately aiming to improve the lives of patients suffering from neurological conditions.
From a downstream perspective, Pharmaceutical Companies accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Neurology CRO Services leading players (including Parexel, Atlantic Research Group, Linical, Biospective, InnoSer, MDB Neuro, Charles River Laboratories, MCRA, Syneos Health, Biotrial, etc.), dominate supply; the top five capture approximately % of global revenue, with Parexel leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Neurology CRO Services market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Parexel
- Atlantic Research Group
- Linical
- Biospective
- InnoSer
- MDB Neuro
- Charles River Laboratories
- MCRA
- Syneos Health
- Biotrial
- Allucent
- Cromos Pharma
- Lindus Health
- TFS HealthScience
- Worldwide Clinical Trials
- Quotient Sciences
- PharPoint Research
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Clinical Trial Management Services
- Pre-clinical Research Services
- Others
Segment by Application
- Pharmaceutical Companies
- Academic Research Organizations
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Neurology CRO Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Neurology CRO Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neurology CRO Services Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Clinical Trial Management Services
1.2.3 Pre-clinical Research Services
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Neurology CRO Services Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Academic Research Organizations
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neurology CRO Services Revenue Estimates and Forecasts (2021-2032)
2.2 Global Neurology CRO Services Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Neurology CRO Services Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Neurology CRO Services Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Clinical Trial Management Services: Market Share by Key Players
3.3.2 Pre-clinical Research Services: Market Share by Key Players
3.3.3 Others: Market Share by Key Players
3.4 Global Neurology CRO Services Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Neurology CRO Services Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Neurology CRO Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Neurology CRO Services Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Neurology CRO Services Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Neurology CRO Services Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Neurology CRO Services Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Neurology CRO Services Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Neurology CRO Services Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Neurology CRO Services Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Neurology CRO Services Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Neurology CRO Services Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Neurology CRO Services Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Parexel
11.1.1 Parexel Corporation Information
11.1.2 Parexel Business Overview
11.1.3 Parexel Neurology CRO Services Product Features and Attributes
11.1.4 Parexel Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.1.5 Parexel Neurology CRO Services Revenue by Product in 2025
11.1.6 Parexel Neurology CRO Services Revenue by Application in 2025
11.1.7 Parexel Neurology CRO Services Revenue by Geographic Area in 2025
11.1.8 Parexel Neurology CRO Services SWOT Analysis
11.1.9 Parexel Recent Developments
11.2 Atlantic Research Group
11.2.1 Atlantic Research Group Corporation Information
11.2.2 Atlantic Research Group Business Overview
11.2.3 Atlantic Research Group Neurology CRO Services Product Features and Attributes
11.2.4 Atlantic Research Group Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.2.5 Atlantic Research Group Neurology CRO Services Revenue by Product in 2025
11.2.6 Atlantic Research Group Neurology CRO Services Revenue by Application in 2025
11.2.7 Atlantic Research Group Neurology CRO Services Revenue by Geographic Area in 2025
11.2.8 Atlantic Research Group Neurology CRO Services SWOT Analysis
11.2.9 Atlantic Research Group Recent Developments
11.3 Linical
11.3.1 Linical Corporation Information
11.3.2 Linical Business Overview
11.3.3 Linical Neurology CRO Services Product Features and Attributes
11.3.4 Linical Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.3.5 Linical Neurology CRO Services Revenue by Product in 2025
11.3.6 Linical Neurology CRO Services Revenue by Application in 2025
11.3.7 Linical Neurology CRO Services Revenue by Geographic Area in 2025
11.3.8 Linical Neurology CRO Services SWOT Analysis
11.3.9 Linical Recent Developments
11.4 Biospective
11.4.1 Biospective Corporation Information
11.4.2 Biospective Business Overview
11.4.3 Biospective Neurology CRO Services Product Features and Attributes
11.4.4 Biospective Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.4.5 Biospective Neurology CRO Services Revenue by Product in 2025
11.4.6 Biospective Neurology CRO Services Revenue by Application in 2025
11.4.7 Biospective Neurology CRO Services Revenue by Geographic Area in 2025
11.4.8 Biospective Neurology CRO Services SWOT Analysis
11.4.9 Biospective Recent Developments
11.5 InnoSer
11.5.1 InnoSer Corporation Information
11.5.2 InnoSer Business Overview
11.5.3 InnoSer Neurology CRO Services Product Features and Attributes
11.5.4 InnoSer Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.5.5 InnoSer Neurology CRO Services Revenue by Product in 2025
11.5.6 InnoSer Neurology CRO Services Revenue by Application in 2025
11.5.7 InnoSer Neurology CRO Services Revenue by Geographic Area in 2025
11.5.8 InnoSer Neurology CRO Services SWOT Analysis
11.5.9 InnoSer Recent Developments
11.6 MDB Neuro
11.6.1 MDB Neuro Corporation Information
11.6.2 MDB Neuro Business Overview
11.6.3 MDB Neuro Neurology CRO Services Product Features and Attributes
11.6.4 MDB Neuro Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.6.5 MDB Neuro Recent Developments
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Corporation Information
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Neurology CRO Services Product Features and Attributes
11.7.4 Charles River Laboratories Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.7.5 Charles River Laboratories Recent Developments
11.8 MCRA
11.8.1 MCRA Corporation Information
11.8.2 MCRA Business Overview
11.8.3 MCRA Neurology CRO Services Product Features and Attributes
11.8.4 MCRA Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.8.5 MCRA Recent Developments
11.9 Syneos Health
11.9.1 Syneos Health Corporation Information
11.9.2 Syneos Health Business Overview
11.9.3 Syneos Health Neurology CRO Services Product Features and Attributes
11.9.4 Syneos Health Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.9.5 Syneos Health Recent Developments
11.10 Biotrial
11.10.1 Biotrial Corporation Information
11.10.2 Biotrial Business Overview
11.10.3 Biotrial Neurology CRO Services Product Features and Attributes
11.10.4 Biotrial Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Allucent
11.11.1 Allucent Corporation Information
11.11.2 Allucent Business Overview
11.11.3 Allucent Neurology CRO Services Product Features and Attributes
11.11.4 Allucent Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.11.5 Allucent Recent Developments
11.12 Cromos Pharma
11.12.1 Cromos Pharma Corporation Information
11.12.2 Cromos Pharma Business Overview
11.12.3 Cromos Pharma Neurology CRO Services Product Features and Attributes
11.12.4 Cromos Pharma Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.12.5 Cromos Pharma Recent Developments
11.13 Lindus Health
11.13.1 Lindus Health Corporation Information
11.13.2 Lindus Health Business Overview
11.13.3 Lindus Health Neurology CRO Services Product Features and Attributes
11.13.4 Lindus Health Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.13.5 Lindus Health Recent Developments
11.14 TFS HealthScience
11.14.1 TFS HealthScience Corporation Information
11.14.2 TFS HealthScience Business Overview
11.14.3 TFS HealthScience Neurology CRO Services Product Features and Attributes
11.14.4 TFS HealthScience Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.14.5 TFS HealthScience Recent Developments
11.15 Worldwide Clinical Trials
11.15.1 Worldwide Clinical Trials Corporation Information
11.15.2 Worldwide Clinical Trials Business Overview
11.15.3 Worldwide Clinical Trials Neurology CRO Services Product Features and Attributes
11.15.4 Worldwide Clinical Trials Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.15.5 Worldwide Clinical Trials Recent Developments
11.16 Quotient Sciences
11.16.1 Quotient Sciences Corporation Information
11.16.2 Quotient Sciences Business Overview
11.16.3 Quotient Sciences Neurology CRO Services Product Features and Attributes
11.16.4 Quotient Sciences Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.16.5 Quotient Sciences Recent Developments
11.17 PharPoint Research
11.17.1 PharPoint Research Corporation Information
11.17.2 PharPoint Research Business Overview
11.17.3 PharPoint Research Neurology CRO Services Product Features and Attributes
11.17.4 PharPoint Research Neurology CRO Services Revenue and Gross Margin (2021-2026)
11.17.5 PharPoint Research Recent Developments
12 Neurology CRO Services Value Chain and Ecosystem Analysis
12.1 Neurology CRO Services Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Neurology CRO Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Neurology CRO Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Neurology CRO Services Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Neurology CRO Services Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Neurology CRO Services Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Neurology CRO Services Revenue by Region (US$ Million), 2021-2026
Table 5. Global Neurology CRO Services Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Neurology CRO Services Revenue by Players (US$ Million), 2021-2026
Table 8. Global Neurology CRO Services Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Neurology CRO Services Revenue, 2025
Table 11. Global Neurology CRO Services Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Neurology CRO Services Companies Headquarters
Table 13. Global Neurology CRO Services Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Neurology CRO Services Revenue by Type (US$ Million), 2021-2026
Table 17. Global Neurology CRO Services Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Neurology CRO Services Revenue by Application (US$ Million), 2021-2026
Table 20. Global Neurology CRO Services Revenue by Application (US$ Million), 2027-2032
Table 21. Neurology CRO Services High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Neurology CRO Services Growth Accelerators and Market Barriers
Table 25. North America Neurology CRO Services Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Neurology CRO Services Growth Accelerators and Market Barriers
Table 27. Europe Neurology CRO Services Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Neurology CRO Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Neurology CRO Services Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Neurology CRO Services Investment Opportunities and Key Challenges
Table 31. Central and South America Neurology CRO Services Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Neurology CRO Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Neurology CRO Services Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Parexel Corporation Information
Table 35. Parexel Description and Major Businesses
Table 36. Parexel Product Features and Attributes
Table 37. Parexel Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Parexel Revenue Proportion by Product in 2025
Table 39. Parexel Revenue Proportion by Application in 2025
Table 40. Parexel Revenue Proportion by Geographic Area in 2025
Table 41. Parexel Neurology CRO Services SWOT Analysis
Table 42. Parexel Recent Developments
Table 43. Atlantic Research Group Corporation Information
Table 44. Atlantic Research Group Description and Major Businesses
Table 45. Atlantic Research Group Product Features and Attributes
Table 46. Atlantic Research Group Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Atlantic Research Group Revenue Proportion by Product in 2025
Table 48. Atlantic Research Group Revenue Proportion by Application in 2025
Table 49. Atlantic Research Group Revenue Proportion by Geographic Area in 2025
Table 50. Atlantic Research Group Neurology CRO Services SWOT Analysis
Table 51. Atlantic Research Group Recent Developments
Table 52. Linical Corporation Information
Table 53. Linical Description and Major Businesses
Table 54. Linical Product Features and Attributes
Table 55. Linical Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. Linical Revenue Proportion by Product in 2025
Table 57. Linical Revenue Proportion by Application in 2025
Table 58. Linical Revenue Proportion by Geographic Area in 2025
Table 59. Linical Neurology CRO Services SWOT Analysis
Table 60. Linical Recent Developments
Table 61. Biospective Corporation Information
Table 62. Biospective Description and Major Businesses
Table 63. Biospective Product Features and Attributes
Table 64. Biospective Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Biospective Revenue Proportion by Product in 2025
Table 66. Biospective Revenue Proportion by Application in 2025
Table 67. Biospective Revenue Proportion by Geographic Area in 2025
Table 68. Biospective Neurology CRO Services SWOT Analysis
Table 69. Biospective Recent Developments
Table 70. InnoSer Corporation Information
Table 71. InnoSer Description and Major Businesses
Table 72. InnoSer Product Features and Attributes
Table 73. InnoSer Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. InnoSer Revenue Proportion by Product in 2025
Table 75. InnoSer Revenue Proportion by Application in 2025
Table 76. InnoSer Revenue Proportion by Geographic Area in 2025
Table 77. InnoSer Neurology CRO Services SWOT Analysis
Table 78. InnoSer Recent Developments
Table 79. MDB Neuro Corporation Information
Table 80. MDB Neuro Description and Major Businesses
Table 81. MDB Neuro Product Features and Attributes
Table 82. MDB Neuro Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. MDB Neuro Recent Developments
Table 84. Charles River Laboratories Corporation Information
Table 85. Charles River Laboratories Description and Major Businesses
Table 86. Charles River Laboratories Product Features and Attributes
Table 87. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Charles River Laboratories Recent Developments
Table 89. MCRA Corporation Information
Table 90. MCRA Description and Major Businesses
Table 91. MCRA Product Features and Attributes
Table 92. MCRA Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. MCRA Recent Developments
Table 94. Syneos Health Corporation Information
Table 95. Syneos Health Description and Major Businesses
Table 96. Syneos Health Product Features and Attributes
Table 97. Syneos Health Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Syneos Health Recent Developments
Table 99. Biotrial Corporation Information
Table 100. Biotrial Description and Major Businesses
Table 101. Biotrial Product Features and Attributes
Table 102. Biotrial Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Biotrial Recent Developments
Table 104. Allucent Corporation Information
Table 105. Allucent Description and Major Businesses
Table 106. Allucent Product Features and Attributes
Table 107. Allucent Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Allucent Recent Developments
Table 109. Cromos Pharma Corporation Information
Table 110. Cromos Pharma Description and Major Businesses
Table 111. Cromos Pharma Product Features and Attributes
Table 112. Cromos Pharma Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Cromos Pharma Recent Developments
Table 114. Lindus Health Corporation Information
Table 115. Lindus Health Description and Major Businesses
Table 116. Lindus Health Product Features and Attributes
Table 117. Lindus Health Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Lindus Health Recent Developments
Table 119. TFS HealthScience Corporation Information
Table 120. TFS HealthScience Description and Major Businesses
Table 121. TFS HealthScience Product Features and Attributes
Table 122. TFS HealthScience Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. TFS HealthScience Recent Developments
Table 124. Worldwide Clinical Trials Corporation Information
Table 125. Worldwide Clinical Trials Description and Major Businesses
Table 126. Worldwide Clinical Trials Product Features and Attributes
Table 127. Worldwide Clinical Trials Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Worldwide Clinical Trials Recent Developments
Table 129. Quotient Sciences Corporation Information
Table 130. Quotient Sciences Description and Major Businesses
Table 131. Quotient Sciences Product Features and Attributes
Table 132. Quotient Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. Quotient Sciences Recent Developments
Table 134. PharPoint Research Corporation Information
Table 135. PharPoint Research Description and Major Businesses
Table 136. PharPoint Research Product Features and Attributes
Table 137. PharPoint Research Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. PharPoint Research Recent Developments
Table 139. Technologies, Platforms and Infrastructure
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurology CRO Services Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Clinical Trial Management Services Product Picture
Figure 3. Pre-clinical Research Services Product Picture
Figure 4. Others Product Picture
Figure 5. Global Neurology CRO Services Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Global Neurology CRO Services Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Pharmaceutical Companies
Figure 8. Academic Research Organizations
Figure 9. Others
Figure 10. Neurology CRO Services Report Years Considered
Figure 11. Global Neurology CRO Services Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 13. Global Neurology CRO Services Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Global Neurology CRO Services Revenue-Based Market Share by Region (2021-2032)
Figure 15. Global Neurology CRO Services Revenue-Based Market Share Ranking (2025)
Figure 16. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 17. Clinical Trial Management Services Revenue-Based Market Share by Player in 2025
Figure 18. Pre-clinical Research Services Revenue-Based Market Share by Player in 2025
Figure 19. Others Revenue-Based Market Share by Player in 2025
Figure 20. Global Neurology CRO Services Revenue-Based Market Share by Type (2021-2032)
Figure 21. Global Neurology CRO Services Revenue-Based Market Share by Application (2021-2032)
Figure 22. North America Neurology CRO Services Revenue YoY (US$ Million), 2021-2032
Figure 23. North America Top 5 Players Neurology CRO Services Revenue (US$ Million) in 2025
Figure 24. North America Neurology CRO Services Revenue (US$ Million) by Application (2021-2032)
Figure 25. US Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 26. Canada Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 27. Mexico Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 28. Europe Neurology CRO Services Revenue YoY (US$ Million), 2021-2032
Figure 29. Europe Top 5 Players Neurology CRO Services Revenue (US$ Million) in 2025
Figure 30. Europe Neurology CRO Services Revenue (US$ Million) by Application (2021-2032)
Figure 31. Germany Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 32. France Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 33. U.K. Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 34. Italy Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 35. Russia Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 36. Asia-Pacific Neurology CRO Services Revenue YoY (US$ Million), 2021-2032
Figure 37. Asia-Pacific Top 8 Players Neurology CRO Services Revenue (US$ Million) in 2025
Figure 38. Asia-Pacific Neurology CRO Services Revenue (US$ Million) by Application (2021-2032)
Figure 39. Indonesia Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 40. Japan Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 41. South Korea Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 42. Australia Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 43. India Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 44. Indonesia Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 45. Vietnam Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 46. Malaysia Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 47. Philippines Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 48. Singapore Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 49. Central and South America Neurology CRO Services Revenue YoY (US$ Million), 2021-2032
Figure 50. Central and South America Top 5 Players Neurology CRO Services Revenue (US$ Million) in 2025
Figure 51. Central and South America Neurology CRO Services Revenue (US$ Million) by Application (2021-2032)
Figure 52. Brazil Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 53. Argentina Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 54. Middle East and Africa Neurology CRO Services Revenue YoY (US$ Million), 2021-2032
Figure 55. Middle East and Africa Top 5 Players Neurology CRO Services Revenue (US$ Million) in 2025
Figure 56. Middle East and Africa Neurology CRO Services Revenue (US$ Million) by Application (2021-2032)
Figure 57. GCC Countries Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 58. Israel Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 59. Egypt Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 60. South Africa Neurology CRO Services Revenue (US$ Million), 2021-2032
Figure 61. Neurology CRO Services Value Chain Mapping
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Neurology CRO Services market size from 2026 to 2032?
The annual compound growth rate of the global Neurology CRO Services market is 5.3% 2026 to 2032.
Which region is expected to have the highest market share?
What was the global market size of Neurology CRO Services in 2026?
Which companies rank high in the global Neurology CRO Services market?
What was the global market size of Neurology CRO Services in 2032?
Related Reports
Global Neurology CRO Services Market Research Report 2026
The global Neurology CRO Services market was valued at US$ 763 million in 2025 and is anticipated to reach US$ 1090 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 127
USD 2900.00
(Single User License)
Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurology CRO Services market size was US$ 763 million in 2025 and is forecast to reach a readjusted size of US$ 1090 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 104
USD 4250.00
(Single User License)
Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurology CRO Services was estimated to be worth US$ 763 million in 2025 and is projected to reach US$ 1090 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 131
USD 3950.00
(Single User License)
Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurology CRO Services was estimated to be worth US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-05-08
Pages: 122
USD 3950.00
(Single User License)
Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurology CRO Services market size was US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-05-08
Pages: 106
USD 4250.00
(Single User License)
Global Neurology CRO Services Market Insights, Forecast to 2031
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Published Date: 2025-05-08
Pages: 156
USD 4900.00
(Single User License)
Global Neurology CRO Services Market Research Report 2025
The global market for Neurology CRO Services was valued at US$ 724 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-05-08
Pages: 91
USD 2900.00
(Single User License)
Global Neurology CRO Services Market Research Report 2026
The global Neurology CRO Services market was valued at US$ 763 million in 2025 and is anticipated to reach US$ 1090 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-11
Pages: 127
USD 2900.00 (Single User License)Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurology CRO Services market size was US$ 763 million in 2025 and is forecast to reach a readjusted size of US$ 1090 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 104
USD 4250.00 (Single User License)Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurology CRO Services was estimated to be worth US$ 763 million in 2025 and is projected to reach US$ 1090 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-03-09
Pages: 131
USD 3950.00 (Single User License)Neurology CRO Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurology CRO Services was estimated to be worth US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 122
USD 3950.00 (Single User License)Global Neurology CRO Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurology CRO Services market size was US$ 724 million in 2024 and is forecast to a readjusted size of US$ 1040 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-05-08
Pages: 106
USD 4250.00 (Single User License)Global Neurology CRO Services Market Insights, Forecast to 2031
The global Neurology CRO Services market is projected to grow from US$ 763 million in 2025 to US$ 1040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Published: 2025-05-08
Pages: 156
USD 4900.00 (Single User License)Global Neurology CRO Services Market Research Report 2025
The global market for Neurology CRO Services was valued at US$ 724 million in the year 2024 and is projected to reach a revised size of US$ 1040 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-05-08
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now